ARTICLE | Clinical News
DP-VPA regulatory update
June 30, 2014 7:00 AM UTC
D-Pharm said partner Jiangsu NHWA received notice that China Food and Drug Administration (CFDA) granted Fast Track designation to DP-VPA to treat epilepsy. D-Pharm said Jiangsu NHWA plans to begin a ...